484 related articles for article (PubMed ID: 28394923)
21. Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice.
Tamura K; Minami K; Kudo M; Iemoto K; Takahashi H; Seino S
PLoS One; 2015; 10(5):e0126003. PubMed ID: 25938469
[TBL] [Abstract][Full Text] [Related]
22. Liraglutide Enhances Autophagy and Promotes Pancreatic β Cell Proliferation to Ameliorate Type 2 Diabetes in High-Fat-Fed and Streptozotocin-Treated Mice.
Fan M; Jiang H; Zhang Y; Ma Y; Li L; Wu J
Med Sci Monit; 2018 Apr; 24():2310-2316. PubMed ID: 29664069
[TBL] [Abstract][Full Text] [Related]
23. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
[TBL] [Abstract][Full Text] [Related]
24. In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes.
Skarbaliene J; Rigbolt KT; Fosgerau K; Billestrup N
Eur J Pharmacol; 2017 Nov; 815():181-189. PubMed ID: 28928089
[TBL] [Abstract][Full Text] [Related]
25. Puerarin protects pancreatic β-cell survival via PI3K/Akt signaling pathway.
Li Z; Shangguan Z; Liu Y; Wang J; Li X; Yang S; Liu S
J Mol Endocrinol; 2014 Aug; 53(1):71-9. PubMed ID: 24827001
[TBL] [Abstract][Full Text] [Related]
26. Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model.
Soto C; Raya L; Juárez J; Pérez J; González I
Phytomedicine; 2014 Feb; 21(3):233-9. PubMed ID: 24176839
[TBL] [Abstract][Full Text] [Related]
27. Central visfatin potentiates glucose-stimulated insulin secretion and β-cell mass without increasing serum visfatin levels in diabetic rats.
Kim DS; Kang S; Moon NR; Park S
Cytokine; 2014 Feb; 65(2):159-66. PubMed ID: 24332931
[TBL] [Abstract][Full Text] [Related]
28. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
29. PI3Kγ ablation does not promote diabetes in
Breasson L; Sardi C; Becattini B; Zani F; Solinas G
FASEB J; 2018 Jan; 32(1):319-329. PubMed ID: 28904022
[TBL] [Abstract][Full Text] [Related]
30. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
[TBL] [Abstract][Full Text] [Related]
31. Chronic orexin-A (hypocretin-1) treatment of type 2 diabetic rats improves glucose control and beta-cell functions.
Kaczmarek P; Skrzypski M; Pruszynska-Oszmalek E; Sassek M; Kolodziejski PA; Billert M; Szczepankiewicz D; Wojciechowicz T; Maechler P; Nowak KW; Strowski MZ
J Physiol Pharmacol; 2017 Oct; 68(5):669-681. PubMed ID: 29375041
[TBL] [Abstract][Full Text] [Related]
32. Constitutively active heat shock factor 1 enhances glucose-driven insulin secretion.
Uchiyama T; Tomono S; Utsugi T; Ohyama Y; Nakamura T; Tomura H; Kawazu S; Okajima F; Kurabayashi M
Metabolism; 2011 Jun; 60(6):789-98. PubMed ID: 20817212
[TBL] [Abstract][Full Text] [Related]
33. Enhancing β-cell function and identity in type 2 diabetes: The protective role of Coptis deltoidea C. Y. Cheng et Hsiao via glucose metabolism modulation and AMPK signaling activation.
Zhang S; Zhang Y; Wen Z; Chen Y; Bu T; Yang Y; Ni Q
Phytomedicine; 2024 Jun; 128():155396. PubMed ID: 38547617
[TBL] [Abstract][Full Text] [Related]
34. Exercise improves glucose homeostasis that has been impaired by a high-fat diet by potentiating pancreatic beta-cell function and mass through IRS2 in diabetic rats.
Park S; Hong SM; Lee JE; Sung SR
J Appl Physiol (1985); 2007 Nov; 103(5):1764-71. PubMed ID: 17761790
[TBL] [Abstract][Full Text] [Related]
35. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
[TBL] [Abstract][Full Text] [Related]
36. Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway.
Xin C; Liu J; Zhang J; Zhu D; Wang H; Xiong L; Lee Y; Ye J; Lian K; Xu C; Zhang L; Wang Q; Liu Y; Tao L
Int J Obes (Lond); 2016 Mar; 40(3):443-51. PubMed ID: 26403433
[TBL] [Abstract][Full Text] [Related]
37. 16,17-Dihydro-17b-hydroxy isomitraphylline alkaloid as an inhibitor of DPP-IV, and its effect on incretin hormone and β-cell proliferation in diabetic rat.
Shukla A; Srinivasan BP
Eur J Pharm Sci; 2012 Sep; 47(2):512-9. PubMed ID: 22820565
[TBL] [Abstract][Full Text] [Related]
38. Liraglutide combined with human umbilical cord mesenchymal stem cell transplantation inhibits beta-cell apoptosis via mediating the ASK1/JNK/BAX pathway in rats with type 2 diabetes.
Wang W; Wu RD; Chen P; Xu XJ; Shi XZ; Huang LH; Shao ZL; Guo W
Diabetes Metab Res Rev; 2020 Feb; 36(2):e3212. PubMed ID: 31411368
[TBL] [Abstract][Full Text] [Related]
39. The Soybean Peptide Vglycin Preserves the Diabetic β-cells through Improvement of Proliferation and Inhibition of Apoptosis.
Jiang H; Tong Y; Yan D; Jia S; Ostenson CG; Chen Z
Sci Rep; 2015 Oct; 5():15599. PubMed ID: 26510947
[TBL] [Abstract][Full Text] [Related]
40. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
